CD19 and B-cell non-Hodgkin lymphoma: CD19 CAR T-cells were detected to proliferate in the peripheral blood of all patients and the median time to reach the peak was 4.5 (range: 1–12) days after infusion in patients with R/R B-cell lymphoma compared with 12 (range: 5–19) days in patients who were MRD positive.